Mullin Monica, Djerboua Maya, Sarkar Monika, Lu Jacquie, Velez Maria P, Brogly Susan, Terrault Norah A, Flemming Jennifer A
Department of Medicine, Queen's University, Canada.
ICES, Queen's University, Canada.
Int J Hepatol. 2022 Jul 6;2022:9985226. doi: 10.1155/2022/9985226. eCollection 2022.
Childbirth in women with cirrhosis is increasing and associated with a higher risk of perinatal outcomes compared to the general population. Whether pregnancy influences the risk of liver-related events compared to nonpregnant women with cirrhosis is unclear. This study evaluates the association between pregnancy and liver-related outcomes in women with compensated cirrhosis. . Population-based retrospective matched cohort study in Ontario, Canada, using routinely collected healthcare data. Pregnant women with compensated cirrhosis and without prior history of decompensation between 2000 and 2016 were identified and matched to nonpregnant women with compensated cirrhosis on age, etiology of cirrhosis, and socioeconomic status in a 1 : 2 ratio. The association between pregnancy and the composite outcome of nonmalignant decompensation, liver transplant (LT), and death up to two years after cohort entry was estimated using the multivariate Cox proportional hazard regression adjusting for potential confounders. Overall, 5,403 women with compensated cirrhosis were included (1,801 pregnant; 3,602 nonpregnant; median age 31 years (IQR 27-34); 60% nonalcoholic fatty liver disease, 34% viral hepatitis). After two years of follow-up, only 19 (1.1%) pregnant women had a liver-related event compared to 319 (8.9%) nonpregnant women. Pregnant women with compensated cirrhosis had a lower hazard of a liver-related event compared to nonpregnant women (aHR 0.14, 95% CI 0.09-0.22, < .001).
Pregnancy in women with compensated cirrhosis is not associated with increased liver-related events compared to nonpregnant women. These results can facilitate counselling women with cirrhosis of child-bearing age and suggests that pregnancy may not accelerate liver disease progression.
肝硬化女性的分娩率正在上升,与普通人群相比,其围产期结局风险更高。与未怀孕的肝硬化女性相比,怀孕是否会影响肝脏相关事件的风险尚不清楚。本研究评估了代偿期肝硬化女性怀孕与肝脏相关结局之间的关联。在加拿大安大略省进行基于人群的回顾性匹配队列研究,使用常规收集的医疗保健数据。识别出2000年至2016年间患有代偿期肝硬化且无失代偿病史的孕妇,并按照1:2的比例将其与年龄、肝硬化病因和社会经济地位相匹配的未怀孕代偿期肝硬化女性进行配对。使用多变量Cox比例风险回归对潜在混杂因素进行调整,估计怀孕与队列进入后两年内非恶性失代偿、肝移植(LT)和死亡的复合结局之间的关联。总体而言,纳入了5403名代偿期肝硬化女性(1801名孕妇;3602名未怀孕女性;中位年龄31岁(四分位间距27 - 34岁);60%为非酒精性脂肪性肝病,34%为病毒性肝炎)。经过两年的随访,只有19名(1.1%)孕妇发生了肝脏相关事件,而未怀孕女性为319名(8.9%)。与未怀孕女性相比,患有代偿期肝硬化的孕妇发生肝脏相关事件的风险更低(校正风险比0.14,95%置信区间0.09 - 0.22,P <.001)。
与未怀孕女性相比,代偿期肝硬化女性怀孕与肝脏相关事件增加无关。这些结果有助于为育龄期肝硬化女性提供咨询,并表明怀孕可能不会加速肝病进展。